Tags » Flu Vaccine

Glaxo Recalls Flu Vaccine Due To Potency Problem

WASHINGTON (AP) — GlaxoSmithKline is recalling a popular four-in-one flu vaccine because its effectiveness can decline over time.

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu. 366 more words

News

Glaxo Recalls Flu Vaccine Due to Potency Problem

WASHINGTON — GlaxoSmithKline is recalling a popular four-in-one flu vaccine because its effectiveness can decline over time.

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu. 370 more words

News

Flu vaccines: Swallowing hype down under

Travel and lifestyle writer Leah McLennan of the Australian Associated Press was out of her depth in What’s new in 2015 flu vaccine?, a feature that ran on Australia’s leading news site, news.com.au. 534 more words

Featured Headline

Chapter CII: Vaccine Controversy

Chapter CII: Vaccine Controversy

Immunitātiōnēs initiālēs utī variōlātiōnum cūrātiōnēs administrātae erant,

vaccinātiōnis methodī esse successi contrā morbum virulēntum probāverint,

corporātiōnēs fūrtīvī modificātiōnēs cum cōnsequēntiā maleficā factīverint. 5,172 more words

Chapters

NACCHO Health News : Indigenous children now able to access free flu vaccine in Australia.

“For the first time, Indigenous children are able to access free flu vaccine in Australia

This is important because Aboriginal and Torres Strait Islander children are… 1,032 more words

Aboriginal Health In The News

MMR vaccine contains recombinant HUMAN albumin

I know, i know really big words, but lets explain.

The growth medium for rubella is Minimum Essential Medium (MEM) containing recombinant human albumin and neomycin. 74 more words

NEWS

Battling Influenza

I’ve been out fighting a form of Influenza. Don’t know which numbers and letters—N3H2, N1H1…A, B—but it was a hard-fought battle and I remained victorious. 1,820 more words

Patti's Pathways